Stay updated on AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial

Sign up to get notified when there's something new on the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the clinical trial record for the AG-270 study, including its design, eligibility criteria, locations, and record details, instead of a 403 Forbidden screen.
    Difference
    73%
    Check dated 2026-11-08T15:08:08.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T16:13:47.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice says the agency is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T18:49:43.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T22:31:56.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:32:20.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page currently returns a 403 Forbidden error instead of displaying the study record. The visible content is limited to the error message and site chrome, indicating access restrictions rather than changes to the trial details.
    Difference
    21%
    Check dated 2026-09-20T19:52:20.000Z thumbnail image

Stay in the know with updates to AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page.